OM
NASDAQOutset Medical Inc.
Website
News25/Ratings12
News · 26 weeks47+100%
2025-10-262026-04-19
Mix2190d
- Other7(33%)
- Insider7(33%)
- SEC Filings5(24%)
- Earnings1(5%)
- Leadership1(5%)
Latest news
25 items- INSIDERSEC Form 4 filed by Elliott Derick A.4 - Outset Medical, Inc. (0001484612) (Issuer)
- INSIDERSEC Form 3 filed by new insider Elliott Derick A.3 - Outset Medical, Inc. (0001484612) (Issuer)
- PROutset Medical Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)SAN JOSE, Calif., April 08, 2026 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (NASDAQ:OM), a medical technology company pioneering a first of-its-kind technology to improve clinical outcomes in dialysis with less cost and complexity (the "Company"), today announced that the Compensation Committee of its Board of Directors approved equity awards under the Company's Inducement Plan, as a material inducement to employment to Derick Elliott, the Company's newly appointed Executive Vice President of Commercial, as well as one newly appointed non-executive employee, in each case, who were not previous employees or directors of the Company. The equity awards were approved in accordance with Nasdaq Li
- PROutset Medical Names Derick Elliott as Executive Vice President of CommercialSAN JOSE, Calif., April 06, 2026 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (NASDAQ:OM), a medical technology company pioneering a first-of-its-kind technology to improve clinical outcomes in dialysis with less cost and complexity, today announced the appointment of Derick Elliott as Executive Vice President of Commercial, effective immediately. Mr. Elliott is responsible for Outset's commercial organizations supporting acute, post-acute and home healthcare providers, reporting to Chair and CEO Leslie Trigg. He joins Outset with more than 30 years of sales and marketing experience from Stryker, Cardinal Health and most recently SpendMend, a private company where he successfully drove a comm
- SECAmendment: SEC Form SCHEDULE 13G/A filed by Outset Medical Inc.SCHEDULE 13G/A - Outset Medical, Inc. (0001484612) (Subject)
- INSIDERAmendment: New insider Leonard Braden Michael claimed ownership of 1,902,201 shares (SEC Form 3)3/A - Outset Medical, Inc. (0001484612) (Issuer)
- INSIDERGeneral Counsel Brottem John L. sold $9,521 worth of shares (2,842 units at $3.35), decreasing direct ownership by 8% to 32,935 units (SEC Form 4)4 - Outset Medical, Inc. (0001484612) (Issuer)
- INSIDERChair and CEO Trigg Leslie sold $11,259 worth of shares (3,361 units at $3.35), decreasing direct ownership by 3% to 102,342 units (SEC Form 4)4 - Outset Medical, Inc. (0001484612) (Issuer)
- INSIDEREVP Operations R&D & Service Nash Marc sold $6,087 worth of shares (1,817 units at $3.35), decreasing direct ownership by 4% to 39,988 units (SEC Form 4)4 - Outset Medical, Inc. (0001484612) (Issuer)
- SECSEC Form 144 filed by Outset Medical Inc.144 - Outset Medical, Inc. (0001484612) (Subject)
- SECAmendment: SEC Form SCHEDULE 13G/A filed by Outset Medical Inc.SCHEDULE 13G/A - Outset Medical, Inc. (0001484612) (Subject)
- SECAmendment: SEC Form SCHEDULE 13G/A filed by Outset Medical Inc.SCHEDULE 13G/A - Outset Medical, Inc. (0001484612) (Subject)
- INSIDERNew insider Leonard Braden Michael claimed ownership of 1,902,201 shares (SEC Form 3)3 - Outset Medical, Inc. (0001484612) (Issuer)
- SECAmendment: SEC Form SCHEDULE 13G/A filed by Outset Medical Inc.SCHEDULE 13G/A - Outset Medical, Inc. (0001484612) (Subject)
- SECSEC Form S-8 filed by Outset Medical Inc.S-8 - Outset Medical, Inc. (0001484612) (Filer)
- SECSEC Form 10-K filed by Outset Medical Inc.10-K - Outset Medical, Inc. (0001484612) (Filer)
- SECOutset Medical Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - Outset Medical, Inc. (0001484612) (Filer)
- SECSEC Form SCHEDULE 13G filed by Outset Medical Inc.SCHEDULE 13G - Outset Medical, Inc. (0001484612) (Subject)
- SECOutset Medical Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits8-K - Outset Medical, Inc. (0001484612) (Filer)
- PRNext-Generation Tablo Hemodialysis System Receives FDA Clearance, Second Quarter Launch PlannedSAN JOSE, Calif., Jan. 27, 2026 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (NASDAQ:OM), a medical technology company pioneering a first-of-its-kind technology to improve clinical outcomes in dialysis with less cost and complexity, today announced 510(k) clearance by the U.S. Food and Drug Administration (FDA) of its next-generation Tablo platform, designed to deliver enterprise-level security, reliability and connectivity for hospitals, health systems and home providers of dialysis. With the clearance, Tablo becomes the first hemodialysis system incorporating FDA's most rigorous and recent guidance on medical device cybersecurity published in June 2025. Additionally, enhancements to the har
- PROutset Medical to Report Fourth Quarter 2025 Financial Results on Wednesday, February 11, 2026SAN JOSE, Calif., Jan. 26, 2026 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (NASDAQ:OM) ("Outset"), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that it will release financial results for the fourth quarter and full-year 2025 after the close of trading on Wednesday, February 11, 2026. On the same day, at 1:30 p.m. Pacific time (4:30 p.m. Eastern time), Leslie Trigg, Chair and Chief Executive Officer, and Renee Gaeta, Chief Financial Officer, will host a conference call to discuss financial and operating results. Conference Call DetailsThe conference call will begin at 1:30 p.m. Pacific time (4:30 p.m. E
- INSIDEREVP Operations R&D & Service Nash Marc sold $32,400 worth of shares (6,355 units at $5.10), decreasing direct ownership by 13% to 41,805 units (SEC Form 4)4 - Outset Medical, Inc. (0001484612) (Issuer)
- INSIDERGeneral Counsel Brottem John L. sold $53,599 worth of shares (10,494 units at $5.11), decreasing direct ownership by 23% to 35,777 units (SEC Form 4)4 - Outset Medical, Inc. (0001484612) (Issuer)
- INSIDERChair and CEO Trigg Leslie sold $71,091 worth of shares (13,914 units at $5.11), decreasing direct ownership by 12% to 105,703 units (SEC Form 4)4 - Outset Medical, Inc. (0001484612) (Issuer)
- SECSEC Form 144 filed by Outset Medical Inc.144 - Outset Medical, Inc. (0001484612) (Subject)